Development of Multinational Definitions of Minimal Clinically Important Improvement and Patient Acceptable Symptomatic State in Osteoarthritis-Reference-Cited by-同舟云学术

Development of Multinational Definitions of Minimal Clinically Important Improvement and Patient Acceptable Symptomatic State in Osteoarthritis

Published:2015-06-25 Issue:7 Volume:67 Page:972-980
ISSN:2151-464X
Container-title:Arthritis Care & Research
language:en
Short-container-title:Arthritis Care & Research

Author:

Bellamy Nicholas¹,Hochberg Marc²,Tubach Florence³,Martin-Mola Emilio⁴,Awada Hassane⁵,Bombardier Claire⁶,Hajjaj-Hassouni Najia⁷,Logeart Isabelle⁸,Matucci-Cerinic Marco⁹,van de Laar Mart¹⁰,van der Heijde Désirée¹¹,Dougados Maxime¹²

Affiliation:

1. University of Queensland School of Medicine, Brisbane, Queensland, Australia, and Royal Brisbane and Women's Hospital; Herston Queensland Australia

2. University of Maryland School of Medicine; Baltimore

3. Université Paris Diderot, Sorbonne Paris Cité, INSERM, UMR-S 1123, INSERM, CIC 1425-EC, UMR-S 1123, and AP-HP Hôpital Bichat; Paris France

4. Hospital Universitario La Paz and Universidad Autónoma Madrid; Madrid Spain

5. Saint Joseph University Hôtel-Dieu de France; Beirut Lebanon

6. University of Toronto, Toronto General Research Institute, Institute for Work and Health, and Mount Sinai Hospital; Toronto Ontario Canada

7. Mohammed Vth Souissi University, CNRST, and Laboratory of Information and Research on Bone Diseases (LIRPOS-URAC 30), Rabat, Morocco, and El Ayachi Hospital and University Hospital; Salé Morocco

8. Pfizer; Paris France

9. Denothe Centre; University of Florence; Florence Italy

10. Arthritis Center Twente; Medisch Spectrum Twente, and University Twente; Enschede The Netherlands

11. Leiden University Medical Center; Leiden The Netherlands

12. Paris Descartes University; Cochin Hospital; AP-HP; INSERM (U1153); PRES Sorbonne Paris-Cité; Paris France

Funder

Merck, Sharp, & Dohme (MSD) Chibret Laboratories.

Publisher

Wiley

Subject

Rheumatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/acr.22538/fullpdf

Reference43 articles.

1. Design and conduct of clinical trials in patients with osteoarthritis: recommendations from a task force of the Osteoarthritis Research Society. Results from a workshop. Osteoarthritis;Altman;Cartilage,1996

2. Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis: consensus development at OMERACT III;Bellamy;J Rheumatol,1997

3. US Department of Health and Human Services http://www.fda.gov/downloads/Drugs/Guidances/UCM193282.pdf

4. Special article: response criteria for clinical trials on osteoarthritis of the knee and hip. A report of the Osteoarthritis Research Society International Standing Committee for Clinical Trials Response Criteria Initiative. Osteoarthritis;Dougados;Cartilage,2000

5. OMERACT-OARSI Initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited. Osteoarthritis;Pham;Cartilage,2004

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Evaluation of Patient-reported Outcome Measures and Minimal Clinically Important Difference Usage in Hand Surgery;Plastic and Reconstructive Surgery - Global Open;2023-12

2. Methotrexate to treat hand osteoarthritis with synovitis (METHODS): an Australian, multisite, parallel-group, double-blind, randomised, placebo-controlled trial;The Lancet;2023-11

3. Novel Tools to Approach and Measure Outcomes in Patients with Fractures;Hand Clinics;2023-11

4. Associations between pain sensitization and measures of physical function in people with hand osteoarthritis: Results from the Nor-Hand study;Osteoarthritis and Cartilage;2023-10

5. Combined Digital Interventions for Pain Reduction in Patients Undergoing Knee Replacement;JAMA Network Open;2023-09-15